3SBio moves on Europe expansion plan with €300m CB
Chinese biopharmaceutical firm 3SBio has taken a step towards boosting its presence in Europe by printing its debut convertible bond, raising €300m in a rare appearance in the currency from an Asian issuer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: